NASA hunt for missing satellite money, New Scientist 132 (1795): 22-22 Nov 16.

Soviets search for partners in space, New Scientist 132 (1793): 17-18 Nov 2.

Will Europe spaceplane leave the drawing board, New Scientist 132 (1791): 13-13 Oct 19.

Satellites strike back against solar flares, New Scientist 132 (1791): 23-23 Oct 19.

Navigating the northeast passage, New Scientist 132 (1791): 23-23 Oct 19.

Hotol hitches a lift from the Soviets, New Scientist 132 (1791): 23-23 Oct.

NASA told to think small on climate satellites, New Scientist 132 (1789): 11-11 Oct 5.

Gamma rays burst onto an unsuspecting world, New Scientist 132 (1789): 18-18 Oct 5.

United States cities breathe easier with oxygenated fuels, New Scientist 131 (1788): 27-27 Sep 28.

United States looks forward to Soviet space sale, New Scientist 131 (1787): 17-17 Sep 21.

Satellite to probe the roof of the sky, New Scientist 131 (1786): 27-27 Sep 14.

Hubbles gyros put NASA in a spin, New Scientist 131 (1780): 7-7 Aug 3.

Journal rekindles row over Silver Springs monkeys, New Scientist 131 (1776): 15-15 Jul 6.

Mission to Mars will need nuclear power, New Scientists 130 (1774): 15-15 Jun 22.

NASA pays high price to save space station, New Scientist 130 (1765): 23-23 Apr 20.

Hubble mirror image heads for the skies, New Scientist 130 (1763): 22-22 Apr 6.

Intercepting the messenger of cosmic violence, New Scientist 129 (1762): 12-13 Mar 30.

Cut price space station runs out of steam, New Scientist 129 (1761): 13-13 Mar 23.

Infrared - the astronomer's favourite wavelength, New Scientist 129 (1761): 16-16 Mar 23.

Congress to smooth path for nuclear power, New Scientist 129 (1760): 12-12 Mar 16.

Tobacco warning, New Scientist 129 (1757): 18-18 Feb 23.

Cleaned up probe on course for Mars, New Scientist 135 (1834): 5-5 Aug 15.

NASA at the end of its tether over reel problems, New Scientist 135 (1834): 5-5 Aug 15.

Electric power from satellite on a string, New Scientist 135 (1832): 19-19 Aug 1.

NASA cuts back to win over Congress, New Scientist 134 (1823): 19-19 4-4 May 30.

Zoo animals do it better, New Scientist 134 (1823): 4-4 May 30.

Satellites peer through window to the galaxy, New Scientist 134 (1823): 20-20 May 30.

NASA celebrates its spacewalking endeavours, New Scientist 134 (1822): 8-8 May 23.

Wobbly start for space salvage crew, New Scientist 134 (1821): 9-9 May 16.

Animal experiments the American Way, New Scientist 134 (1821): 4 pages, May 16

Galactic neighbour may harbor a black hole, New Scientist 134 (1818): 16-16 Apr 25.

Green research gains ground in America, New Scientist 134 (1817): 8-8 Apr 18.

Nervous NASA awaits its new supremo, New Scientist 133 (1813): 13-13 Mar 21.

Washington takes a stand on biotechnology, New Scientist 133 (1811): 10-10 Mar 7.

Plans for NASA database too vague, New Scientist 133 (1811): 22-22 Mar 7.

NASA resignation leaves room at the top, New Scientist 133 (1809): 11-11 Feb 22.

Bush budget boosts civil science, New Scientist 133 (1807): 14-14 Feb 8.

UFO spotters get clean bill of health, New Scientist 140 (1898): 5-5 Nov 6.

Will cash cut backs spell the end for freedom, New Scientist 137 (1865): 6-6 Mar 20.

Clinton plans technology push to boost growth, New Scientist 137 (1864): 7-7 Mar 13.

Much of this year was spent in tracking down new sources for my book, Something New Under the Sun ...

NIH should rethink pricing clause, Nature 372 (6506): 488-488 Dec 8.

Fetal gene therapy under the micrsocope - as US bans embryos for research, Nature 372 (6506): 490-490 Dec 8.

ORI finds Imanishi-Kari guilty of misconduct, proposes 10-year ban, Nature 372 (6505): 391-391 Dec 1 1994.

NIH seeks bids for vector centers for gene therapy, Nature 372 (6504): 306-306 Nov 24.

Researchers face delay in supplies of RU486, Nature 372 (6503): 209-209 Nov 17.

Varmus speaks out on need to boost clinical research, Nature 372 (6502): 118-118 Nov 10.

Tunisian Institute to tackle secrets of Malaria genome, Nature 371 (6500): 732-732 Oct 27.

Study proposed on integrity of published data, Nature 371 (6500): 733-733 Oct 27.

Gene advisory group switches focus to ethical issues, Nature 371 (6497): 468-468 Oct 6.

NIH gets the green light on embryo research, Nature 371 (6496): 370-370 Sept 29.

Koop may set up new center for alternative medicine, Nature 370 (6491): 591-591 Aug 25.

Search launched for lowest addictive nicotine level, Nature 370 (6489): 402-402 Aug 11.

Lack of behaviour studies is hampering AIDs prevention, Nature 370 (6488): 316-316 Aug 4.

Reasonable pricing may be dropped from NIH deals, Nature 370 (6487): 238-238 Jul 28.

Peer Review - NIH urged to streamline bids, Nature 370 (6486): 170-171 Jul 21.

FDA claims nicotine levels were manipulated, Nature 369 (6483): 696-696 Jun 30.

Trials must compete for new funds, Nature 396 (6481): 515-515 Jun 16.

Doubts greet violence research funding plea..., Nature 369 (6480): 430-430 Jun 9.

... as NIH tightens up on Academic-Industry deals, Nature 369 (6480): 430-430 Jun 9.

Cautious welcome to NIH peer-review reforms, Nature 369 (6478): 269-269 May 26.

Genetics business booming yet uncertain, Nature 369 (6478): 341-342 May 26.

NIH rejects Persian Gulf Syndrome, Nature 369 (6475): 8-8 May 5.

Cancer Institute to tighten control of trials, Nature 368 (6473): 679-679 Apr 21.

Kessler adds heat to smoke debate, Nature 368 (6470): 382-382 Mar 31.

Commission Redefines Ethical Research Practices, Nature Medicine 1(9): 859-860 Sept.

The Whistle-Blowers' view, Nature Medicine 1(9): 859-859 Sept.

Waiving informed consent for unconscious patients, Nature Medicine 1 (7): 612-612 July.

Did you know?, Nature Medicine 1 (4): 292-292 Apr.

Industry sceptical on new gene therapy review, Nature Medicine 1 (4): 292-292 Apr.

Clinical research and the need for follow up, Nature Medicine 1 (8): 727-727 Aug.

Health insurance debate stirs trouble for genetic testing, Nature Medicine 1 (8): 733-733 Aug.

Senators voice frustration, White House proposes reform of FDA, Nature Medicine 1 (5): 390-390 May.

A shot in the arm for gene therapy company, Nature Medicine 1(5): 392-392 May.

A prescription for clinical research, Nature Medicine 1 (6): 496-496 Jun.

New oversight for peer review, Nature Medicine 1 (6): 498-498 Jun.

Embryo research tests NIHS mettle, Nature Medicine 1 (1): 5-6 Jan.

Future perfect or imperfect, Nature Medicine 1 (3): 186-187 Mar.

NIH drops reasonable pricing clause, Nature 374 (6524): 669-669 Apr.

Congress turns spotlight on US drug approval agency, Nature 374 (6523): 582-582 Apr 13.

NIH wins patent on basic technique covering all ex-vivo gene therapy, Nature 374 (6521): 393-393 Mar 30.

US lead falters in technology race, Nature 374 (397-397): Mar 30.

NIH to review priorities in readiness for future cuts, Nature 374 (6519): 202-202 Mar 16.

Gene-therapy approval may be rocky road for industry, Nature 374 (6519): 202-202 Mar 16.

US sets up new bioethics advisory board, Nature 374 (6519): 202-202 Mar 16.

AIDS activists seek speedy access to protease drugs --- as companies plan combination trials, Nature 374 (6517): 4-4 Mar 2 1995.

NIH resolves dispute on cancer gene patent, Nature 373 (6516): 649-649 Feb 23.

Medical schools fight their corner, Nature 373 (6516): 649-649 Feb 23.

NIH in line with expectations, Nature 373 (6514): 461-461 Feb 9.

Smithsonian to study museums role after dropping A-bomb exhibition, Nature 373 (6513): 371-371 Feb 2.

AIDs activists fail to block reasonable pricing reform, Nature 373 (6512): 272-272 Jan 26.

Clinical trials face lack of minority-group volunteers, Nature 373 (6511): 178-178 Jan 19.